Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Light therapy for preventing seasonal affective disorder.

Nussbaumer-Streit B, Forneris CA, Morgan LC, Van Noord MG, Gaynes BN, Greenblatt A, Wipplinger J, Lux LJ, Winkler D, Gartlehner G.

Cochrane Database Syst Rev. 2019 Mar 18;3:CD011269. doi: 10.1002/14651858.CD011269.pub3.

PMID:
30883670
2.

Second-generation antidepressants for preventing seasonal affective disorder in adults.

Gartlehner G, Nussbaumer-Streit B, Gaynes BN, Forneris CA, Morgan LC, Greenblatt A, Wipplinger J, Lux LJ, Van Noord MG, Winkler D.

Cochrane Database Syst Rev. 2019 Mar 18;3:CD011268. doi: 10.1002/14651858.CD011268.pub3.

PMID:
30883669
3.

User testing of an adaptation of fishbone diagrams to depict results of systematic reviews.

Gartlehner G, Schultes MT, Titscher V, Morgan LC, Bobashev GV, Williams P, West SL.

BMC Med Res Methodol. 2017 Dec 12;17(1):169. doi: 10.1186/s12874-017-0452-z.

4.

Comparative Benefits and Harms of Complementary and Alternative Medicine Therapies for Initial Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.

Asher GN, Gartlehner G, Gaynes BN, Amick HR, Forneris C, Morgan LC, Coker-Schwimmer E, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN.

J Altern Complement Med. 2017 Dec;23(12):907-919. doi: 10.1089/acm.2016.0261. Epub 2017 Jul 12. Review.

PMID:
28700248
5.

Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians.

Gartlehner G, Gaynes BN, Amick HR, Asher GN, Morgan LC, Coker-Schwimmer E, Forneris C, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN.

Ann Intern Med. 2016 Mar 1;164(5):331-41. doi: 10.7326/M15-1813. Epub 2015 Dec 8. Review.

PMID:
26857743
6.

Management and Outcomes of Binge-Eating Disorder [Internet].

Berkman ND, Brownley KA, Peat CM, Lohr KN, Cullen KE, Morgan LC, Bann CM, Wallace IF, Bulik CM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Dec.

7.

Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder [Internet].

Gartlehner G, Gaynes BN, Amick HR, Asher G, Morgan LC, Coker-Schwimmer E, Forneris C, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Dec.

8.

Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis.

Amick HR, Gartlehner G, Gaynes BN, Forneris C, Asher GN, Morgan LC, Coker-Schwimmer E, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN.

BMJ. 2015 Dec 8;351:h6019. doi: 10.1136/bmj.h6019. Review.

9.

Melatonin and agomelatine for preventing seasonal affective disorder.

Kaminski-Hartenthaler A, Nussbaumer B, Forneris CA, Morgan LC, Gaynes BN, Sonis JH, Greenblatt A, Wipplinger J, Lux LJ, Winkler D, Van Noord MG, Hofmann J, Gartlehner G.

Cochrane Database Syst Rev. 2015 Nov 11;(11):CD011271. doi: 10.1002/14651858.CD011271.pub2. Review.

PMID:
26560173
10.

Psychological therapies for preventing seasonal affective disorder.

Forneris CA, Nussbaumer B, Kaminski-Hartenthaler A, Morgan LC, Gaynes BN, Sonis JH, Greenblatt A, Wipplinger J, Lux LJ, Winkler D, Van Noord MG, Hofmann J, Gartlehner G.

Cochrane Database Syst Rev. 2015 Nov 11;(11):CD011270. doi: 10.1002/14651858.CD011270.pub2. Review.

PMID:
26560172
11.

Light therapy for preventing seasonal affective disorder.

Nussbaumer B, Kaminski-Hartenthaler A, Forneris CA, Morgan LC, Sonis JH, Gaynes BN, Greenblatt A, Wipplinger J, Lux LJ, Winkler D, Van Noord MG, Hofmann J, Gartlehner G.

Cochrane Database Syst Rev. 2015 Nov 8;(11):CD011269. doi: 10.1002/14651858.CD011269.pub2. Review. Update in: Cochrane Database Syst Rev. 2019 Mar 18;3:CD011269.

PMID:
26558494
12.

Second-generation antidepressants for preventing seasonal affective disorder in adults.

Gartlehner G, Nussbaumer B, Gaynes BN, Forneris CA, Morgan LC, Kaminski-Hartenthaler A, Greenblatt A, Wipplinger J, Lux LJ, Sonis JH, Hofmann J, Van Noord MG, Winkler D.

Cochrane Database Syst Rev. 2015 Nov 8;(11):CD011268. doi: 10.1002/14651858.CD011268.pub2. Review. Update in: Cochrane Database Syst Rev. 2019 Mar 18;3:CD011268.

PMID:
26558418
13.

Grading the strength of a body of evidence when assessing health care interventions: an EPC update.

Berkman ND, Lohr KN, Ansari MT, Balk EM, Kane R, McDonagh M, Morton SC, Viswanathan M, Bass EB, Butler M, Gartlehner G, Hartling L, McPheeters M, Morgan LC, Reston J, Sista P, Whitlock E, Chang S.

J Clin Epidemiol. 2015 Nov;68(11):1312-24. doi: 10.1016/j.jclinepi.2014.11.023. Epub 2014 Dec 20.

PMID:
25721570
14.

Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis.

Nussbaumer B, Morgan LC, Reichenpfader U, Greenblatt A, Hansen RA, Van Noord M, Lux L, Gaynes BN, Gartlehner G.

CNS Drugs. 2014 Aug;28(8):699-712. doi: 10.1007/s40263-014-0169-z. Review.

PMID:
24794101
15.

Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence.

Garbutt JC, Greenblatt AM, West SL, Morgan LC, Kampov-Polevoy A, Jordan HS, Bobashev GV.

Addiction. 2014 Aug;109(8):1274-84. doi: 10.1111/add.12557. Epub 2014 May 23. Review.

PMID:
24661324
16.

Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.

Reichenpfader U, Gartlehner G, Morgan LC, Greenblatt A, Nussbaumer B, Hansen RA, Van Noord M, Lux L, Gaynes BN.

Drug Saf. 2014 Jan;37(1):19-31. doi: 10.1007/s40264-013-0129-4. Review.

PMID:
24338044
17.

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.

Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ, Jordan HS, Kendall KA, Lux LJ, Mentor-Marcel R, Morgan LC, Trisolini MG, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society.

Circulation. 2014 Jun 24;129(25 Suppl 2):S102-38. doi: 10.1161/01.cir.0000437739.71477.ee. Epub 2013 Nov 12. No abstract available. Erratum in: Circulation. 2014 Jun 24;129(25 Suppl 2):S139-40.

18.

2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS, Lee IM, Lichtenstein AH, Loria CM, Millen BE, Nonas CA, Sacks FM, Smith SC Jr, Svetkey LP, Wadden TA, Yanovski SZ, Kendall KA, Morgan LC, Trisolini MG, Velasco G, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Circulation. 2014 Jun 24;129(25 Suppl 2):S76-99. doi: 10.1161/01.cir.0000437740.48606.d1. Epub 2013 Nov 12. No abstract available. Erratum in: Circulation. 2014 Jun 24;129(25 Suppl 2):S100-1. Circulation. 2015 Jan 27;131(4):e326.

PMID:
24222015
19.

Interrater reliability of grading strength of evidence varies with the complexity of the evidence in systematic reviews.

Berkman ND, Lohr KN, Morgan LC, Kuo TM, Morton SC.

J Clin Epidemiol. 2013 Oct;66(10):1105-1117.e1. doi: 10.1016/j.jclinepi.2013.06.002.

PMID:
23993312
20.

A case study of pooled-studies publications indicated potential for both valuable information and bias.

Thaler KJ, Morgan LC, Van Noord M, Jonas DE, McDonagh MS, Peterson K, Glechner A, Gartlehner G.

J Clin Epidemiol. 2013 Oct;66(10):1082-92. doi: 10.1016/j.jclinepi.2013.05.002. Epub 2013 Jul 10. Review.

PMID:
23850407
21.

Findings of Bayesian Mixed Treatment Comparison Meta-Analyses: Comparison and Exploration Using Real-World Trial Data and Simulation [Internet].

Jonas DE, Wilkins TM, Bangdiwala S, Bann CM, Morgan LC, Thaler KJ, Amick HR, Gartlehner G.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Feb.

22.

Reliability Testing of the AHRQ EPC Approach to Grading the Strength of Evidence in Comparative Effectiveness Reviews [Internet].

Berkman ND, Lohr KN, Morgan LC, Richmond E, Kuo TM, Morton S, Viswanathan M, Kamerow D, West S, Tant E.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 May.

23.

Drug Therapy for Rheumatoid Arthritis in Adults: An Update [Internet].

Donahue KE, Jonas DE, Hansen RA, Roubey R, Jonas B, Lux LJ, Gartlehner G, Harden E, Wilkins T, Peravali V, Bangdiwala SI, Yuen A, Thieda P, Morgan LC, Crotty K, Desai R, Van Noord M.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Apr.

24.

Drug Therapy for Psoriatic Arthritis in Adults: Update of a 2007 Report [Internet].

Donahue KE, Jonas D, Hansen RA, Roubey R, Jonas B, Lux LJ, Gartlehner G, Harden E, Yuen A, Thieda P, Morgan LC, Crotty K, Van Noord M.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Apr.

25.

Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.

Thaler KJ, Morgan LC, Van Noord M, Gaynes BN, Hansen RA, Lux LJ, Krebs EE, Lohr KN, Gartlehner G.

Depress Anxiety. 2012 Jun;29(6):495-505. doi: 10.1002/da.21951. Epub 2012 May 2. Review.

PMID:
22553134
26.

Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review [Internet].

Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux LJ, Van Noord M, Mager U, Gaynes BN, Thieda P, Strobelberger M, Lloyd S, Reichenpfader U, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Dec.

27.

Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis.

Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, Mager U, Thieda P, Gaynes BN, Wilkins T, Strobelberger M, Lloyd S, Reichenpfader U, Lohr KN.

Ann Intern Med. 2011 Dec 6;155(11):772-85. doi: 10.7326/0003-4819-155-11-201112060-00009. Review.

PMID:
22147715
28.

Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults [Internet].

Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas B, Hansen RA, Morgan LC, Williams SC, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Nov.

29.

Drug Class Review: Targeted Immune Modulators: Final Report Update 2 [Internet].

Gartlehner G, Thieda P, Morgan LC, Thaler K, Hansen RA, Jonas B.

Portland (OR): Oregon Health & Science University; 2009 Nov.

30.

Drug Class Review: Controller Medications for Asthma: Final Report [Internet].

Jonas DE, Kiser K, Shilliday BB, Morgan LC, Thieda P, Reuland D.

Portland (OR): Oregon Health & Science University; 2008 Nov.

31.

Drug Class Review: Second Generation Antidepressants: Final Report Update 4 [Internet].

Gartlehner G, Morgan LC, Thieda P, Thaler K, Hansen RA, Gaynes B, Lohr KN, Carey TS.

Portland (OR): Oregon Health & Science University; 2008 Oct.

32.

Enhancing the use and quality of colorectal cancer screening.

Holden DJ, Harris R, Porterfield DS, Jonas DE, Morgan LC, Reuland D, Gilchrist M, Viswanathan M, Lohr KN, Lyda-McDonald B.

Evid Rep Technol Assess (Full Rep). 2010 Feb;(190):1-195, v. Review.

33.

Outcomes and costs of community health worker interventions: a systematic review.

Viswanathan M, Kraschnewski JL, Nishikawa B, Morgan LC, Honeycutt AA, Thieda P, Lohr KN, Jonas DE.

Med Care. 2010 Sep;48(9):792-808. doi: 10.1097/MLR.0b013e3181e35b51. Review.

PMID:
20706166
34.

Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression [Internet].

Gartlehner G, Hansen RA, Thieda P, DeVeaugh-Geiss AM, Gaynes BN, Krebs EE, Lux LJ, Morgan LC, Shumate JA, Monroe LG, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Jan.

35.

Drug Class Review: Constipation Drugs: Final Report [Internet].

Gartlehner G, Jonas DE, Morgan LC, Ringel Y, Hansen RA, Bryant CM, Carey T.

Portland (OR): Oregon Health & Science University; 2007 Sep.

36.

Semi-automating the manual literature search for systematic reviews increases efficiency.

Chapman AL, Morgan LC, Gartlehner G.

Health Info Libr J. 2010 Mar;27(1):22-7. doi: 10.1111/j.1471-1842.2009.00865.x.

37.

Inadequate reporting of trials compromises the applicability of systematic reviews.

Gartlehner G, Thieda P, Hansen RA, Morgan LC, Shumate JA, Nissman DB.

Int J Technol Assess Health Care. 2009 Jul;25(3):323-30. doi: 10.1017/S0266462309990122. Review.

PMID:
19619351
38.

Outcomes of community health worker interventions.

Viswanathan M, Kraschnewski J, Nishikawa B, Morgan LC, Thieda P, Honeycutt A, Lohr KN, Jonas D; RTI International-University of North Carolina Evidence-based Practice Center.

Evid Rep Technol Assess (Full Rep). 2009 Jun;(181):1-144, A1-2, B1-14, passim. Review.

39.

How reviews covered the unfolding scientific story of gabapentin for bipolar disorder.

Williams JW Jr, Ranney L, Morgan LC, Whitener L.

Gen Hosp Psychiatry. 2009 May-Jun;31(3):279-87. doi: 10.1016/j.genhosppsych.2009.02.006. Epub 2009 Apr 5. Review.

PMID:
19410108
40.

Gabapentin in the treatment of mental illness: the echo chamber of the case series.

Carey TS, Williams JW Jr, Oldham JM, Goodman F, Ranney LM, Whitener L, Morgan LC, Melvin CL.

J Psychiatr Pract. 2008 Mar;14 Suppl 1:15-27. doi: 10.1097/01.pra.0000333584.75741.45. Review. Erratum in: J Psychiatr Pract. 2008 May;14(3):193.

PMID:
19034206
41.

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.

Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG, Jonas DE.

Clin Interv Aging. 2008;3(2):211-25. Review.

42.

Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis.

Krebs EE, Gaynes BN, Gartlehner G, Hansen RA, Thieda P, Morgan LC, DeVeaugh-Geiss A, Lohr KN.

Psychosomatics. 2008 May-Jun;49(3):191-8. doi: 10.1176/appi.psy.49.3.191. Review.

PMID:
18448772
43.

Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis.

Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, Hansen RA, Morgan LC, Lohr KN.

Ann Intern Med. 2008 Jan 15;148(2):124-34. Epub 2007 Nov 19. Review.

PMID:
18025440

Supplemental Content

Loading ...
Support Center